A COMPARATIVE CLINICAL STUDY OF KAMDUDHA RASA AND KUSHMANDA RASAYANA IN THE MANAGEMENT OF Gastro Esophageal Reflux Disese

A COMPARATIVE CLINICAL STUDY OF KAMDUDHA RASA AND KUSHMANDA RASAYANA IN THE MANAGEMENT OF AMLAPITTA(GERD) - Amlapitta

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/09/036819

Enrollment

120

Registered

2021-09-24

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K219- Gastro-esophageal reflux disease without esophagitis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: •Patient between the age group of 21 â?? 60 years •Patients diagnosed as Amlapitta /GERD according to Ayurvedic classical features like Avipaka (Indigestion),Utklesha (Nausea),Hrit- Daha (Heartburn),Kantha-Daha(Throatburn),Tikta Udgara (Bitter eructations) ,Amla Udgara (Sour eructations), Chhardi (Vomiting),Aruchi(Anorexia) Shiro-Ruja(Headache). will be randomly selected irrespective of sex, religion and occupation. •Chronicity •The patients who are diagnosed with GERD according to GERDQ QUESTIONAIRE.

Exclusion criteria

Exclusion criteria: •Already diagnosed patient of chronic diseases (cardiovascular diseases, cancer, chronic respiratory diseases, diabetes, chronic orthopedic conditions) with early or late complication. •Patient with the known organic cause of dyspepsia i.e gastric/duodenal ulcer. Patient on long term use of analgesic (atleast for 3 months). •Patient with past history of Gastrointestinal (GI) surgery. Patient not suitable and contraindicated for therapy as assessed by the physician. •Pregnant and lactating mothers. •Patient with alarm features as Family history of upper GI malignancy in a first-degree relative, Unintended weight loss more than 5% of normal body weight over last 6â??12 months, Occult (elicited by past history) or overt GI bleeding (recent history of past 15 days to one month) or iron deficiency anemia, Dysphagia, Odynophagia, Persistent vomiting â??considered when there was more than 3 episodes of vomiting in 24 h in past 15 days to one month.

Design outcomes

Primary

Measure	Time frame
â?¢Assessment of drug by biochemical and physiological parameters.Timepoint: â?¢3MONTHS	—

Secondary

Measure	Time frame
â?¢Symptomatic and overall assessment will be discussed in subjective parameters. â?¢Improvement in quality of life. Timepoint: 3MONTHS	—

Countries

India

Contacts

Public ContactDr Jonah Sandrepogu

All India Institute of Ayurveda

jonahdr@gmail.com9448262298

Outcome results